These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7890061)

  • 1. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
    Ammälä M; Nyman T; Strengell L; Rutanen EM
    Fertil Steril; 1995 Apr; 63(4):773-8. PubMed ID: 7890061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
    Umapathysivam K; Jones WR
    Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system.
    Rutanen EM; Salmi A; Nyman T
    Mol Hum Reprod; 1997 Sep; 3(9):749-54. PubMed ID: 9357999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ.
    Gu Z; Zhu P; Luo H; Zhu X; Zhang G; Wu S
    Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of mRNA for keratinocyte growth factor and its receptor in human endometrium.
    Siegfried S; Pekonen F; Nyman T; Ammälä M
    Acta Obstet Gynecol Scand; 1995 Jul; 74(6):410-4. PubMed ID: 7541595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium.
    Fleming DC; King AE; Williams AR; Critchley HO; Kelly RW
    Fertil Steril; 2003 Apr; 79(4):856-63. PubMed ID: 12749421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the intrauterine contraceptive device on endometrial secretory function: a possible mode of action.
    Seif MW; Aplin JD; Awad H; Wells D
    Contraception; 1989 Jul; 40(1):81-9. PubMed ID: 2476276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion.
    von Wolff M; Thaler CJ; Strowitzki T; Broome J; Stolz W; Tabibzadeh S
    Mol Hum Reprod; 2000 Jul; 6(7):627-34. PubMed ID: 10871650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
    Rutanen E; Hurskainen R; Finne P; Nokelainen K
    Fertil Steril; 2000 May; 73(5):1020-4. PubMed ID: 10785231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua.
    Giudice LC; Dsupin BA; Jin IH; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1993 May; 76(5):1115-22. PubMed ID: 8496300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endometrial interleukin-6 (IL-6): in vivo messenger ribonucleic acid expression, in vitro protein production, and stimulation thereof by IL-1 beta.
    Vandermolen DT; Gu Y
    Fertil Steril; 1996 Nov; 66(5):741-7. PubMed ID: 8893677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles.
    Gargiulo AR; Fichorova RN; Politch JA; Hill JA; Anderson DJ
    Fertil Steril; 2004 Oct; 82 Suppl 3():1226-34. PubMed ID: 15474100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
    Wang IY; Russell P; Fraser IS
    Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of levonorgestrel-releasing intrauterine device (20 micrograms/day) (LNG-IUD-20) on the morphological structure of human endometrium: a study of the endometrial factor VIII activity in the women before and after insertion of LNG-IUD-20 by the digital image analysis.
    Zhu P; Liu X; Luo H; Gu Z; Wang J; Xu L; Cheng J; Xu R; Lian S; Cui Y
    Contraception; 1995 Jul; 52(1):63-8. PubMed ID: 8521717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.